It does seem strange they'd mention mid 2024, particularly when first patient dosed announcement was Jan 17 this year. Assuming at least a 3-4 month follow-up then they're predicting 26 enrolments in the space of a few months? Odd. Would have to be super quick enrolment. They did mention that historically Korea enrolment in pancreatic ca trials has been strong, but this seems a big stretch.
The Korea link is intriguing.
It does seem strange they'd mention mid 2024, particularly when...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.004(5.41%) |
Mkt cap ! $19.01M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.0¢ | $14.65K | 195.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51009 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 52133 | 1 |
View Market Depth
| Last trade - 15.59pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.004 ( 4.05 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.3¢ | 7.0¢ | 2121 | ||
| Last updated 15.08pm 05/06/2024 ? | |||||
| ATX (ASX) Chart |